Among them, Fndc5/Irisin, which is well known to promote the browning of white adipose tissue, enhances muscle hypertrophy and alleviates obesity and hepatic steatosis, was significantly decreased in both NAFLD and NASH groups. Here, FNDC5 is linked to metabolic dysfunction-associated steatohepatitis.